Birchview Capital
GUTS icon

Birchview Capital’s Fractyl Health GUTS Stock Holding History

Birchview Capital’s Portfolio GUTS Stock Details GUTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$90.1K Buy
+13,790
New +$114K 0.05% 75

Other funds holding GUTS

Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.16B AUM 31.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Pale Fire Capital SE
Pale Fire Capital SE Prague, Czech Republic $1.39B AUM 5.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
PEAK6
PEAK6 Chicago, Illinois $54.8B AUM 16.89% 1-Year Est. Return

Birchview Capital's GUTS Position: Q3 2026 in Review

Birchview Capital opened a new position in Fractyl Health (GUTS) in Q3 2026: 13,790 shares worth $90.1K. The stake represents 0.05% of the portfolio and ranks #75 among its holdings.

46 funds tracked by Wall St. Rank hold GUTS as of Q3 2026.

  • Birchview Capital held 13,790 shares of Fractyl Health worth $90.1K as of Q3 2026.
  • Fractyl Health was a new Birchview Capital position in Q3 2026.
  • Fractyl Health made up 0.05% of Birchview Capital's portfolio in Q3 2026, its #75 holding.
  • 46 funds tracked by Wall St. Rank held Fractyl Health as of Q3 2026.

Based on Birchview Capital's 13F filing for Q3 2026, filed 13 Nov 2026.